Tyk2 is a tumor suppressor in colorectal cancer
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 26, 2022 Category: Cancer & Oncology Authors: Stefan Moritsch Bernadette M ödl Irene Scharf Lukas Janker Daniela Zwolanek Gerald Timelthaler Emilio Casanova Maria Sibilia Thomas Mohr Lukas Kenner Dietmar Herndler-Brandstetter Christopher Gerner Mathias M üller Birgit Strobl Robert Eferl Source Type: research
Is ferroptosis immunogenic? The devil is in the details!
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 23, 2022 Category: Cancer & Oncology Authors: Oliver Kepp Guido Kroemer Source Type: research
A novel membrane-bound interleukin-2 promotes NK-92 cell persistence and anti-tumor activity
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 23, 2022 Category: Cancer & Oncology Authors: Qi Xiong Hantao Zhang Xuanle Ji Yong Zhang Gang Shi Lei Dai Fuyi Cheng Huiling Wang Jieyan Luo Jia Xu Yanhong Ji Xiaolan Su Weixiao Yang Lin Zhang Hongxin Deng Source Type: research
Type I interferon induces cancer stem cells-mediated chemotherapy resistance
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 23, 2022 Category: Cancer & Oncology Authors: Mara De Martino Claire Vanpouille-Box Source Type: research
Urinary T cells are detected in patients with immune checkpoint inhibitor-associated immune nephritis that are clonotypically identical to kidney T cell infiltrates
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 22, 2022 Category: Cancer & Oncology Authors: Shailbala Singh Leticia C. Clemente Edwin R. Parra Amanda Tchakarov Chao Yang Yisheng Li James P. Long Cassian Yee Jamie S. Lin Source Type: research
The efficacy and safety of first-line treatment in cisplatin-ineligible advanced upper tract urothelial carcinoma patients: a comparison of PD-1 inhibitor and carboplatin plus gemcitabine chemotherapy
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 17, 2022 Category: Cancer & Oncology Authors: Jiwei Huang Ruopeng Su Zeyu Chen Shuai Jiang Minfeng Chen Yichu Yuan Hailong Hu Changde Fu Zhiyang Huang Zhenyu Wang Bing Zheng Chancan Li Zaoyu Wang Yige Bao Ming Cai Jianming Guo Qiang Wei Wei Xue Source Type: research
Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 13, 2022 Category: Cancer & Oncology Authors: Robby Barnestein Lo ïck Galland Laura Kalfeist Fran çois Ghiringhelli Sylvain Ladoire Emeric Limagne Source Type: research
Targeting DNA damage response components induces enhanced STING-dependent type-I IFN response in ATM deficient cancer cells and drives dendritic cell activation
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 13, 2022 Category: Cancer & Oncology Authors: Marta Lopez-Pelaez Lucy Young Mercedes Vazquez-Chantada Nadine Nelson Steve Durant Robert W. Wilkinson Edmund Poon Miguel Gaspar Viia Valge-Archer Paul Smith Simon J. Dovedi Source Type: research
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 7, 2022 Category: Cancer & Oncology Authors: Paola Storti Valentina Marchica Rosanna Vescovini Valentina Franceschi Luca Russo Laura Notarfranchi Vincenzo Raimondi Denise Toscani Jessica Burroughs Garcia Federica Costa Benedetta Dalla Palma Nicolas Thomas Iannozzi Gabriella Sammarelli Gaetano Donofr Source Type: research
Loss of CD47 alters CD8+ T cell activation in vitro and immunodynamics in mice
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - September 6, 2022 Category: Cancer & Oncology Authors: Pulak R. Nath Dipasmita Pal-Nath Sukhbir Kaur Arunkumar Gangaplara Thomas J. Meyer Margaret C Cam David D. Roberts Source Type: research
CXCL10-armed oncolytic adenovirus promotes tumor-infiltrating T-cell chemotaxis to enhance anti-PD-1 therapy
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 31, 2022 Category: Cancer & Oncology Authors: Xiaofei Li Mingjie Lu Manman Yuan Jing Ye Wei Zhang Lingyan Xu Xiaohan Wu Bingqing Hui Yuchen Yang Bin Wei Ciliang Guo Min Wei Jie Dong Xingxin Wu Yanhong Gu Source Type: research
Nivolumab plus ipilimumab in metastatic uveal melanoma: a real-life, retrospective cohort of 47 patients
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 31, 2022 Category: Cancer & Oncology Authors: H élène Salaün Leanne de Koning Mathilde Saint-Ghislain Vincent Servois Toulsie Ramtohul Agathe Garcia Alexandre Matet Nathalie Cassoux Pascale Mariani Sophie Piperno-Neumann Manuel Rodrigues Source Type: research
CCL22-based peptide vaccines induce anti-cancer immunity by modulating tumor microenvironment
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 29, 2022 Category: Cancer & Oncology Authors: In és Lecoq Katharina L. Kopp Marion Chapellier Panagiotis Mantas Evelina Martinenaite Maria Perez-Penco Lars R ønn Olsen Mai-Britt Zocca Ayako Wakatsuki Pedersen Mads Hald Andersen Source Type: research
IRE1 α overexpression in malignant cells limits tumor progression by inducing an anti-cancer immune response
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 27, 2022 Category: Cancer & Oncology Authors: Adriana Martinez-Turtos Rachel Paul Manuel Grima-Reyes Hussein Issaoui Adrien Krug Rana Mhaidly Jozef P. Bossowski Johanna Chiche Sandrine Marchetti Els Verhoeyen Eric Chevet Jean-Ehrland Ricci Source Type: research
Single-cell RNA-sequencing reveals predictive features of response to pembrolizumab in S ézary syndrome
Volume 11, Issue 1, December 2022 . (Source: OncoImmunology)
Source: OncoImmunology - August 27, 2022 Category: Cancer & Oncology Authors: Tianying Su George E. Duran Alexa C. Kwang Nirasha Ramchurren Steven P. Fling Youn H. Kim Michael S. Khodadoust Source Type: research
